Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Teva Takeda to License 10 APIs/20 Products from Sawai as It Plans to Shutter In-House Plants
Teva Takeda Pharma, a Japanese joint venture of Takeda Pharmaceutical and Teva Pharmaceuticals Industries, will license 10 APIs/20 products from Sawai Pharmaceutical, bracing for its upcoming closure of two plants that are currently manufacturing 31 APIs/61 products. The move is…
To read the full story
Related Article
- Teva Takeda to Shutter 2 Factories in Shiga
April 24, 2019
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





